Mopac Biologics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series 1

  • Latest Deal Amount
  • $4M

  • Investors
  • 2

Mopac Biologics General Information

Description

Provider of oral and topical biologic therapies intended for autoinflammatory diseases. The company utilizes computational protein design technology to discover therapeutics with high potency and resistance to gastrointestinal conditions, addressing inflammatory bowel disease, enabling clinics with safe, effective, and convenient therapies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 600 University Street
  • Suite 3247
  • Seattle, WA 98101-4172
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 600 University Street
  • Suite 3247
  • Seattle, WA 98101-4172
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mopac Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series 1) 10-Mar-2021 $4M Completed Startup
To view Mopac Biologics’s complete valuation and funding history, request access »

Mopac Biologics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series 1
To view Mopac Biologics’s complete cap table history, request access »

Mopac Biologics Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Mopac Biologics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025226984-A1 Human il-17 binding polypeptides Pending 24-Apr-2024

Mopac Biologics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Sahsen Ventures Venture Capital Minority
WRF Capital Corporate Venture Capital Minority
To view Mopac Biologics’s complete investors history, request access »

Ready to get started?

Request a free trial

Mopac Biologics FAQs

  • When was Mopac Biologics founded?

    Mopac Biologics was founded in 2020.

  • Where is Mopac Biologics headquartered?

    Mopac Biologics is headquartered in Seattle, WA.

  • What industry is Mopac Biologics in?

    Mopac Biologics’s primary industry is Drug Discovery.

  • Is Mopac Biologics a private or public company?

    Mopac Biologics is a Private company.

  • What is the current valuation of Mopac Biologics?

    The current valuation of Mopac Biologics is .

  • What is Mopac Biologics’s current revenue?

    The current revenue for Mopac Biologics is .

  • How much funding has Mopac Biologics raised over time?

    Mopac Biologics has raised $4M.

  • Who are Mopac Biologics’s investors?

    Sahsen Ventures and WRF Capital have invested in Mopac Biologics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process